Back to Market返回行情

BCT.TO BriaCell Therapeutics Corp.

TSXHealthcare

$5.03+0.80%ClosedMarket Cap: $9.5M

As of 2026-05-29 15:59

Valuation

P/E (TTM)

-0.34

PEG

—

P/B

0.33

P/S

0.00

EV/EBITDA

0.75

DCF Value

—

FCF Yield

-451.3%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.0%

Operating Margin

0.0%

Net Margin

0.0%

ROE

-166.3%

ROA

-88.2%

ROIC

-100.9%

Income Statement

Periods shown are fiscal year quarters (may differ from calendar year)

Period	Revenue	Gross Margin	Operating Income	Net Income	EPS	Dividend
Q2 2026	$0.00	—	$-7.5M	$-7.2M	$-2.58	—
Q1 2026	$0.00	—	$-8.3M	$-8.2M	$-4.35	—
Q4 2025	$0.00	—	$-8.5M	$-8.1M	$-4.28	—
Q3 2025	$0.00	—	$-6.3M	$-6.1M	$-16.40	—
Q2 2025	$0.00	—	$-7.2M	$-6.3M	$-23.31	—
Q1 2025	$0.00	—	$-5.2M	$-5.8M	$-32.67	—
Q4 2024	$0.00	—	$-5.7M	$-1.2M	$-9.97	—
Q3 2024	$0.00	—	$-9.2M	$1.7M	$15.98	—
Q2 2024	$0.00	—	$-9.9M	$-11.4M	$-106.69	—
Q1 2024	$0.00	—	$-8.4M	$5.9M	$-73.43	—
Q4 2023	$0.00	—	$-7.8M	$-2.4M	$-22.92	—
Q3 2023	$0.00	—	$-5.7M	$-4.9M	$-47.13	—